Chlorcyclizine + cinnarizine
Generic name
Chlorcyclizine + cinnarizine
Brand name
ATC Code
N07CA52
- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
No information available about the pharmacokinetic parameters in children.
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
Available formulations
No information is present at this moment.
Dosages
| Travel sickness |
|---|
|
Renal impaiment in children > 3 months
GFR ≥10 ml/min/1.73m2: Dose adjustment not required.
GFR <10 ml/min/1.73m2: A general recommendation on dose adjustment cannot be provided.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects
No information is present at this moment.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions
No information available on specific warnings and precautions in children.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
ANTIVERTIGO PREPARATIONS
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Antivertigo preparations | ||
|---|---|---|
| N07CA02 | ||
| N07CA03 | ||
References
- Meda Pharma, SmPC Primatour (RVG 03178) 03-03-2015, www.cbg-meb.nl
- KNMP, Zelfzorgstandaard Reisziekte, 2014
Changes
Therapeutic Drug Monitoring
Overdose
